Company news
Intervacc Ab (OMXSTO:IVACC) news
Intervacc Ab news releases on 6ix. Latest, Jul 30, 2026: Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac
Press releases & updates
Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac
July 30, 2026
Intervacc completes successful evaluation of US strain of strangles pathogen ahead of clinical trials
May 22, 2026
Emil Billbäck appointed new Chair of the Board of Intervacc
May 15, 2026
Intervacc strengthens management team for future growth
May 12, 2026
Intervacc publishes the 2025 Annual Report
April 14, 2026
Notice of Annual General Meeting in Intervacc AB (publ)
April 10, 2026
Intervacc announces breakthrough protection against Streptococcus suis infection in piglets
March 19, 2026
Intervacc: New CEO announced
February 6, 2026
Intervacc : and Dechra extend distribution agreement for Intervacc’s equine strangles vaccine Strangvac by two years
October 13, 2025